Delpor, Inc. Report issue

For profit Phase 2
Founded: Brisbane California United States (2009)

Organization Overview

First Clinical Trial
2020
NCT04418466
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Delpor, Inc.